UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
34.54
+0.16 (0.47%)
At close: Jun 26, 2026, 4:00 PM EDT
34.10
-0.44 (-1.27%)
After-hours: Jun 26, 2026, 7:02 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.68 billion as of June 26, 2026. Its market cap has increased by 399.95% in one year.
Market Cap
1.68B
Enterprise Value
1.74B
1-Year Change
399.95%
Ranking
Category
Stock Price
$34.54
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.68B, an increase of 825.15%. That is a compound annual growth rate of 27.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.68B | 53.50% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 1.78B |
| Bicara Therapeutics | 1.77B |
| Zymeworks | 1.76B |
| Innoviva | 1.74B |
| Vir Biotechnology | 1.69B |
| Mesoblast | 1.69B |
| Septerna | 1.68B |
| Fortrea Holdings | 1.67B |